The AHR pathway represses TGFß-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma. (2020)

First Author: Saric N
Attributed to:  A BMI1/CHD7 signature in medulloblastoma with poor prognosis. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-56876-z

PubMed Identifier: 31924815

Publication URI: http://europepmc.org/abstract/MED/31924815

Type: Journal Article/Review

Volume: 10

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322